Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Human Microbiome Therapeutic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Microbiome Therapeutic Drugsmarket, defines the market attractiveness level of Human Microbiome Therapeutic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Microbiome Therapeutic Drugs industry, describes the types of Human Microbiome Therapeutic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Microbiome Therapeutic Drugs market and the development prospects and opportunities of Human Microbiome Therapeutic Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Microbiome Therapeutic Drugs market in Chapter 13.
By Player:
Rebiotix
Bristol-Myers Squibb
Johnson and Johnson
ENTEROME Bioscience
Vedanta Biosciences
Takeda
Seres Therapeutics
By Type:
FMT
Microbiome Drugs
Others
By End-User:
Stomach
Oral
Respiratory Tract
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Microbiome Therapeutic Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Microbiome Therapeutic Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Microbiome Therapeutic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Microbiome Therapeutic Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Microbiome Therapeutic Drugs Market Analysis and Outlook to 2022
-
7.1 Global Human Microbiome Therapeutic Drugs Consumption (2017-2022)
-
7.2 United States Human Microbiome Therapeutic Drugs Consumption (2017-2022)
-
7.3 Europe Human Microbiome Therapeutic Drugs Consumption (2017-2022)
-
7.4 China Human Microbiome Therapeutic Drugs Consumption (2017-2022)
-
7.5 Japan Human Microbiome Therapeutic Drugs Consumption (2017-2022)
-
7.6 India Human Microbiome Therapeutic Drugs Consumption (2017-2022)
-
7.7 South Korea Human Microbiome Therapeutic Drugs Consumption (2017-2022)
8 Region and Country-wise Human Microbiome Therapeutic Drugs Market Analysis and Outlook to 2028
-
8.1 Global Human Microbiome Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.2 United States Human Microbiome Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Human Microbiome Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.4 China Human Microbiome Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Human Microbiome Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.6 India Human Microbiome Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Human Microbiome Therapeutic Drugs Consumption Forecast (2022-2028)
9 Global Human Microbiome Therapeutic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Human Microbiome Therapeutic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global FMT Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Microbiome Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Microbiome Therapeutic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Stomach Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oral Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Respiratory Tract Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Human Microbiome Therapeutic Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Human Microbiome Therapeutic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global FMT Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Microbiome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Microbiome Therapeutic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Stomach Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Respiratory Tract Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Microbiome Therapeutic Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Microbiome Therapeutic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Microbiome Therapeutic Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Microbiome Therapeutic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Microbiome Therapeutic Drugs Market Competitive Analysis
-
14.1 Rebiotix
-
14.1.1 Rebiotix Company Details
-
14.1.2 Rebiotix Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Rebiotix Human Microbiome Therapeutic Drugs Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Product and Service
-
14.3 Johnson and Johnson
-
14.3.1 Johnson and Johnson Company Details
-
14.3.2 Johnson and Johnson Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson and Johnson Human Microbiome Therapeutic Drugs Product and Service
-
14.4 ENTEROME Bioscience
-
14.4.1 ENTEROME Bioscience Company Details
-
14.4.2 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Product and Service
-
14.5 Vedanta Biosciences
-
14.5.1 Vedanta Biosciences Company Details
-
14.5.2 Vedanta Biosciences Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Vedanta Biosciences Human Microbiome Therapeutic Drugs Product and Service
-
14.6 Takeda
-
14.6.1 Takeda Company Details
-
14.6.2 Takeda Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Human Microbiome Therapeutic Drugs Product and Service
-
14.7 Seres Therapeutics
-
14.7.1 Seres Therapeutics Company Details
-
14.7.2 Seres Therapeutics Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Seres Therapeutics Human Microbiome Therapeutic Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Microbiome Therapeutic Drugs
-
Figure Human Microbiome Therapeutic Drugs Picture
-
Table Global Human Microbiome Therapeutic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Microbiome Therapeutic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Microbiome Therapeutic Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Microbiome Therapeutic Drugs Consumption by Country (2017-2022)
-
Figure United States Human Microbiome Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Human Microbiome Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Human Microbiome Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Microbiome Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Human Microbiome Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Microbiome Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Human Microbiome Therapeutic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Human Microbiome Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Microbiome Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Microbiome Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Microbiome Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Microbiome Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Microbiome Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FMT Consumption and Growth Rate (2017-2022)
-
Figure Global Microbiome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Stomach Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Tract Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global FMT Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Microbiome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stomach Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Tract Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Microbiome Therapeutic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Microbiome Therapeutic Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Rebiotix (Foundation Year, Company Profile and etc.)
-
Table Rebiotix Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rebiotix Human Microbiome Therapeutic Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Human Microbiome Therapeutic Drugs Product and Service
-
Table ENTEROME Bioscience (Foundation Year, Company Profile and etc.)
-
Table ENTEROME Bioscience Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ENTEROME Bioscience Human Microbiome Therapeutic Drugs Product and Service
-
Table Vedanta Biosciences (Foundation Year, Company Profile and etc.)
-
Table Vedanta Biosciences Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vedanta Biosciences Human Microbiome Therapeutic Drugs Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Human Microbiome Therapeutic Drugs Product and Service
-
Table Seres Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Seres Therapeutics Human Microbiome Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seres Therapeutics Human Microbiome Therapeutic Drugs Product and Service
-
